Search results for: Determining Value

OHE at ISPOR May 2016: Meet the Team

19 May 2016

…the patient of having greater certainty of treatment benefit. The Paper also identifies several other sources of value related to information, including real option value, the value of hope, insurance…

Eliciting the Relative Value of Life Extension at the End of Life

29 November 2016

…Discussion of presentation by Rachel Baker Perspectives, priorities and plurality Eliciting societal values and the relative value of life extension at the end of life from Office of Health Economics…

Assessing Value, Budget Impact, and Affordability in Asia

10 July 2017

…benefit to be the key component of value, and that there is little consensus around “wider” elements of value that should be included; All systems use budget impact in decision…

Value, Affordability, and Decision Making

Value, Affordability, and Decision Making Efficient allocation of healthcare budgets requires a clear understanding of whether interventions deliver good value for money. Resource-allocation decisions should therefore follow structured, transparent, and…

Operationalising Value Based Pricing of Medicines: A Taxonomy of Approaches

1 August 2011

…the elements of value that could be considered and how these might be measured and valued, combined into an overall assessment of a medicine’s value,and then linked to the maximum…

OHE Lunchtime Seminar: The People’s Prescription – Re-imagining Health Innovation to Deliver Public Value

7 September 2018

OHE Lunchtime Seminar with Mariana Mazzucato on Re-imagining Health Innovation to Deliver Public Value. 28 September 2018 12:00-2:00pm. OHE Lunchtime Seminar with Mariana Mazzucato on ‘The people’s prescription – re-imagining…

OHE Response to Public Consultation on NICE Principles

7 February 2019

…input into more general guidance and value judgements adopted by NICE and its advisory committees. The Social Value Judgements guide states the following: “The NHS is funded from general taxation,…

ISPOR Europe Round-up: “Gene Therapies: Where High Promise Meets High Uncertainty, How Should HTA Methodologies Appropriately Value and Enable Access?”

8 December 2022

…effectiveness, assessment of costs, uncertainty regarding long-term outcomes and incorporating additional value elements. The actionable recommendations focused on better capturing the value of gene therapies and addressing uncertainty in outcomes…

Just Published: Testing the Feasibility of Obtaining EQ-5D-5L Values in the United Arab Emirates

23 October 2015

This study tests the feasibility of eliciting EQ-5D-5L values from a general public sample in the United Arab Emirates. Recently published in Value in Health Regional Issues is a study…